Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantroneAnnika Öhrfelt, Markus Axelsson, Clas Malmeström, et al.Molecular Therapy. Methods & Clinical Development|August 30, 2023
Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathyAlexia Kagiava, Christos Karaiskos, George Lapathitis, et al.Rapid Communications in Mass Spectrometry : RCM|November 5, 2016
Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case studyClaire L Russell, Amanda Heslegrave, Vikram Mitra, et al.Brain and Behavior|August 4, 2022
The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse-onset multiple sclerosisThomas Williams, Amanda Heslegrave, Henrik Zetterberg, et al.The Journal of Biological Chemistry|February 5, 2010
Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthaseNadine Stahmann, Angela Woods, Katrin Spengler, et al.Alzheimer'S Research & Therapy|April 11, 2018
Neurofilament light as a blood biomarker for neurodegeneration in Down syndromeAndre Strydom, Amanda Heslegrave, Carla M Startin, et al.Ebiomedicine|May 9, 2022
Plasma neurofilament light chain protein as a predictor of days in delirium and deep sedation, mortality and length of stay in critically ill patientsValerie J Page, Leiv Otto Watne, Amanda Heslegrave, et al.Journal of Neurovirology|July 30, 2022
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriersDaniel Harding, Carolina Rosadas, Sandra Maria Tsoti, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 10, 2022
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trialThomas Williams, Carmen Tur, Arman Eshaghi, et al.JMIR Aging|May 28, 2025
Longitudinal Remote Sleep and Cognitive Research in Older Adults With Mild Cognitive Impairment and Dementia: Prospective Feasibility Cohort StudyVictoria Grace Gabb, Jonathan Blackman, Hamish Morrison, et al.Pageof 15